Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
Next-generation sequencing: Examining an often oversimplified & misunderstood technology--Part I
In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.
MCL Infectious Specimen Shipping Guidelines MC1235168
MCL Infectious Specimen Shipping Guidelines Infectious Specimen Shipping Guidelines Shipper Responsibilities test send area considered shipper send specimens
Pathways Case Studies: July 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for July include the following sub-specialties: Breast Pathology, Cytopathology &...
Pathways Case Studies: March 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cardiovascular...
Pediatric neuro-oncology informative cases - Insights
Neuro-oncology is a complex field undergoing rapid changes with the advancement and evolution of sophisticated genetic testing. Evidence continues to grow in support of broad molecular and cytogenetic analysis for patients with brain...
July 2019 — Cardiovascular - Insights
A 50-year-old man who was known to have systemic hypertension developed sudden onset of severe back pain with associated diaphoresis. He lost
New Tests Launched in July - Insights
In July 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Collaboration identifies previously unknown blood clotting condition - Insights
A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.
Live and virtual meetings featuring general sessions, breakouts, panel discussions, and case studies, led by laboratory leaders and health care industry experts.